Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,526,523
+$2,681,095 QoQ
Shares Held
9,610
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#1,180
of 4,605 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $27,585,966 across 9 Drug Manufacturers - General names. LLY ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,610 | $11,526,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,231 | $6,661,887 | |
| 3 | ABBV |
AbbVie Inc.
|
18,441 | $4,640,493 | |
| 4 | MRK |
Merck & Co., Inc.
|
32,843 | $4,220,325 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,000 | $288,100 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,354 | $171,064 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 | |
| 8 | GSK |
GSK plc
|
90 | $4,717 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,526,523 | 9,610 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,845,428 | 9,617 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,931,645 | 10,172 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $8,328,908 | 10,916 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,536,633 | 10,951 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,100,702 | 11,019 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $8,289,736 | 10,738 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,762,172 | 11,019 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $9,877,695 | 10,910 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,665,696 | 11,139 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,084,518 | 10,438 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $5,926,692 | 11,034 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,333,240 | 11,372 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,385,090 | 9,857 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,491,211 | 9,543 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,406,694 | 7,443 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,621,749 | 20,423 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,995,724 | 17,445 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,184,733 | 15,150 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $924,200 | 4,000 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $688,560 | 3,000 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||